Literature DB >> 32643791

Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.

Jessica R Blount1, Sean L Johnson1, Kozeta Libohova1, Sokol V Todi1,2, Wei-Ling Tsou1.   

Abstract

Ataxin-3 is a deubiquitinase and polyglutamine disease protein whose cellular properties and functions are not entirely understood. Mutations in ataxin-3 cause spinocerebellar ataxia type 3 (SCA3), a neurodegenerative disorder that is a member of the polyglutamine family of diseases. Two major isoforms arise from alternative splicing of ATXN3 and are differently toxic in vivo as a result of faster proteasomal degradation of one isoform compared to the other. The isoforms vary only at their C-termini, suggesting that the hydrophobic C-terminus of the more quickly degraded form of ataxin-3 (here referred to as isoform 2) functions as a degron-that is, a peptide sequence that expedites the degradation of its host protein. We explored this notion in this study and present evidence that: (a) the C-terminus of ataxin-3 isoform 2 signals its degradation in a proteasome-dependent manner, (b) this effect from the C-terminus of isoform 2 does not require the ubiquitination of ataxin-3, and (c) the isolated C-terminus of isoform 2 can enhance the degradation of an unrelated protein. According to our data, the C-terminus of ataxin-3 isoform 2 is a degron, increasing overall understanding of the cellular properties of the SCA3 protein.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  RRID:AB_1281300; RRID:AB_2307391; RRID:SCR_001010; ataxia; deubiquitinase; isoform; neurodegeneration; polyglutamine; proteasome; ubiquitin

Mesh:

Substances:

Year:  2020        PMID: 32643791      PMCID: PMC8693082          DOI: 10.1002/jnr.24684

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  66 in total

1.  Recognition of the polyubiquitin proteolytic signal.

Authors:  J S Thrower; L Hoffman; M Rechsteiner; C M Pickart
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

Review 2.  Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.

Authors:  Carlos A Matos; Luís Pereira de Almeida; Clévio Nóbrega
Journal:  J Neurochem       Date:  2018-10-05       Impact factor: 5.372

3.  3'-UTRs and the Control of Protein Expression in Space and Time.

Authors:  Traude H Beilharz; Michael M See; Peter R Boag
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Substrate recognition in selective autophagy and the ubiquitin-proteasome system.

Authors:  Anne Schreiber; Matthias Peter
Journal:  Biochim Biophys Acta       Date:  2013-03-29

5.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

Authors:  V Chau; J W Tobias; A Bachmair; D Marriott; D J Ecker; D K Gonda; A Varshavsky
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

Review 6.  Ubiquitin-independent proteasomal degradation.

Authors:  Jenny Erales; Philip Coffino
Journal:  Biochim Biophys Acta       Date:  2013-05-14

Review 7.  Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry L Paulson
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Molecular clearance of ataxin-3 is regulated by a mammalian E4.

Authors:  Masaki Matsumoto; Masayoshi Yada; Shigetsugu Hatakeyama; Hiroshi Ishimoto; Teiichi Tanimura; Shoji Tsuji; Akira Kakizuka; Masatoshi Kitagawa; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

Review 10.  Classification of intrinsically disordered regions and proteins.

Authors:  Robin van der Lee; Marija Buljan; Benjamin Lang; Robert J Weatheritt; Gary W Daughdrill; A Keith Dunker; Monika Fuxreiter; Julian Gough; Joerg Gsponer; David T Jones; Philip M Kim; Richard W Kriwacki; Christopher J Oldfield; Rohit V Pappu; Peter Tompa; Vladimir N Uversky; Peter E Wright; M Madan Babu
Journal:  Chem Rev       Date:  2014-04-29       Impact factor: 60.622

View more
  1 in total

Review 1.  A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.

Authors:  Sean L Johnson; Wei-Ling Tsou; Matthew V Prifti; Autumn L Harris; Sokol V Todi
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.